Skip to main content

Neurostimulator clinical trials at University of California Health

1 research study open to eligible people

Showing trials for
  • RNS System RESPONSE Study

    open to eligible people ages 12-17

    To demonstrate that the RNS System is safe and effective as an adjunctive therapy in individuals age 12 through 17 years with medically refractory partial onset epilepsy.

    at UCLA

Last updated: